B cell responses to HIV antigen are a potent correlate of viremia in HIV-1 infection and improve with PD-1 blockade

PloS One
Katherine J NicholasSpyros A Kalams

Abstract

Infection with Human Immunodeficiency Virus Type 1 (HIV-1) induces defects of both cellular and humoral immune responses. Impaired CD4+ T cell help and B cell dysfunction may partially explain the low frequency of broadly neutralizing antibodies in HIV-infected individuals. To understand the extent of B cell dysfunction during HIV infection, we assessed the level of B cell activation at baseline and after stimulation with a variety of antigens. Increased levels of viremia were associated with higher baseline expression of the activation marker CD86 on B cells and with decreased ability of B cells to increase expression of CD86 after in vitro stimulation with inactivated HIV-1. In a series of cell isolation experiments B cell responses to antigen were enhanced in the presence of autologous CD4+ T cells. HIV infected individuals had a higher frequency of PD-1 expression on B cells compared to HIV- subjects and PD-1 blockade improved B cell responsiveness to HIV antigen, suggesting that inhibitory molecule expression during HIV-1 infection may contribute to some of the observed B cell defects. Our findings demonstrate that during chronic HIV infection, B cells are activated and lose full capacity to respond to antigen, but suppres...Continue Reading

References

Dec 26, 1991·The New England Journal of Medicine·M C SteinhoffR E Chaisson
Feb 1, 1992·The Journal of Clinical Investigation·A ShiraiD M Klinman
Jun 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·R PahwaS Pahwa
Aug 16, 2001·Proceedings of the National Academy of Sciences of the United States of America·S MoirA S Fauci
Jan 9, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Frann BennettBeatriz M Carreno
May 6, 2003·Proceedings of the National Academy of Sciences of the United States of America·Susan MoirAnthony S Fauci
Jun 10, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Angela MalaspinaAnthony S Fauci
Aug 19, 2006·Nature Medicine·Lydie TrautmannRafick-Pierre Sekaly
Sep 7, 2006·The Journal of Experimental Medicine·Constantinos PetrovasRichard A Koup
Sep 27, 2006·The Journal of Experimental Medicine·Gordon J FreemanArlene H Sharpe
Dec 17, 2008·Nature·Vijayakumar VeluRama Rao Amara
Dec 29, 2010·Current HIV/AIDS Reports·Alka Khaitan, Derya Unutmaz
May 13, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Joseph A ConradSpyros A Kalams
Jun 3, 2011·The Journal of Clinical Investigation·Lela KardavaAnthony S Fauci
Jun 4, 2011·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Olusimidele T AkinsikuPaul A Goepfert
Jun 10, 2011·Blood·Filippos PorichisDaniel E Kaufmann
Oct 13, 2011·Nature Medicine·Bruce D WalkerStanley Plotkin
Mar 12, 2013·Nature Medicine·Rafael A CubasElias K Haddad

❮ Previous
Next ❯

Citations

Oct 4, 2015·Biochimica Et Biophysica Acta·Yi XiaKen H Young
Nov 13, 2015·Medical Hypotheses·Pashtoon Murtaza KasiStephen M Ansell
Mar 22, 2016·Asia-Pacific Journal of Clinical Oncology·Wee Loon OngJeremy L Millar
Sep 1, 2015·Clinical and Experimental Medicine·Paulina WlasiukKrzysztof Giannopoulos
Mar 11, 2015·Retrovirology·Vijayakumar VeluEsaki M Shankar
Aug 10, 2018·The Journal of Clinical Investigation·Alice R BurtonMala K Maini
Jul 11, 2018·International Journal of Molecular Sciences·Maike SperkUjjwal Neogi
Apr 9, 2020·Frontiers in Immunology·Jil M JubelFrank A Schildberg
May 10, 2018·Scientific Reports·Michaela LucasSilvana Gaudieri
Jan 17, 2019·Molecular Cancer·Xianjie JiangZhaoyang Zeng
Feb 12, 2021·Frontiers in Immunology·Zena N WillsmoreSophia N Karagiannis

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry

Software Mentioned

GraphPad Prism

Related Concepts

Related Feeds

B cell Activation

B cell activation is initiated by the ligation of the B cell receptor with antigen and ultimately results in the production of protective antibodies against potentially pathogenic invaders. Here is the latest research.